Cargando…

Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry

Background: Despite an intensive multimodal treatment approach, approximately 50% of high-risk (HR) neuroblastoma (NB) patients experience progression. Despite the advances in targeted therapy, high-dose chemotherapy, and other systemic treatment options, radiation therapy (RT) to sites of relapsed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jazmati, Danny, Hero, Barbara, Thole.-Kliesch, Theresa M., Merta, Julien, Deubzer, Hedwig E., Bäumer, Christian, Heinzelmann, Feline, Schleithoff, Stefanie Schulze, Koerber, Friederike, Eggert, Angelika, Schwarz, Rudolf, Simon, Thorsten, Timmermann, Beate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689739/ https://www.ncbi.nlm.nih.gov/pubmed/36354709 http://dx.doi.org/10.3390/curroncol29110649

Ejemplares similares

Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry
por: Jazmati, Danny, et al.
Publicado: (2021)

Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study
por: Peters, Sarah, et al.
Publicado: (2021)

Proton Beam Therapy for Pediatric Tumors of the Central Nervous System—Experiences of Clinical Outcome and Feasibility from the KiProReg Study
por: Peters, Sarah, et al.
Publicado: (2022)

Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region – Data From the Prospective Registries ProReg and KiProReg
por: Worawongsakul, Rasin, et al.
Publicado: (2022)

Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004
por: Jazmati, Danny, et al.
Publicado: (2020)

Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma
por: Launspach, Michael, et al.
Publicado: (2021)

Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival
por: Thole, Theresa M, et al.
Publicado: (2017)

Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics
por: Lodrini, Marco, et al.
Publicado: (2022)

Sinusoidal Obstruction Syndrome Following Myeloablative Therapy and Tranexamic Acid Treatment for Hemorrhage in Two Patients with Neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2020)

Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study
por: Ahmad Khalil, Dalia, et al.
Publicado: (2023)

Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma
por: Lodrini, Marco, et al.
Publicado: (2017)

Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma
por: Arnhold, Viktor, et al.
Publicado: (2017)

Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing
por: Szymansky, Annabell, et al.
Publicado: (2021)

Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect
por: Arlt, Birte, et al.
Publicado: (2021)

The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
por: Pajtler, Kristian W, et al.
Publicado: (2016)

Bioprinted Cancer Model of Neuroblastoma in a Renal Microenvironment as an Efficiently Applicable Drug Testing Platform
por: Wu, Dongwei, et al.
Publicado: (2021)

MYCN transcriptionally represses CD9 to trigger an invasion-metastasis cascade in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2015)

Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
por: Flaadt, Tim, et al.
Publicado: (2023)

Endothelial Cell Response to Combined Photon or Proton Irradiation with Doxorubicin
por: Bernardo, Teresa, et al.
Publicado: (2023)

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2016)

Adaptive Proton Therapy of Pediatric Head and Neck Cases Using MRI-Based Synthetic CTs: Initial Experience of the Prospective KiAPT Study
por: Bäumer, Christian, et al.
Publicado: (2022)

Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
por: Kocak, H, et al.
Publicado: (2013)

Germline Mutations Including the Rare Pathogenic Variant c.3206delC in the ATM Gene Cause Ataxia Teleangiectasia-Associated Primary Central Nervous System Lymphoma
por: Dörr, Jan R., et al.
Publicado: (2021)

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions
por: Schmelz, Karin, et al.
Publicado: (2021)

Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
por: Fuchs, Steffen, et al.
Publicado: (2023)

RITA displays anti-tumor activity in medulloblastomas independent of TP53 status
por: Gottlieb, Aline, et al.
Publicado: (2017)

Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer
por: Ahmad Khalil, Dalia, et al.
Publicado: (2022)

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
por: Lodrini, Marco, et al.
Publicado: (2013)

Controversial Canadian regs.
por: Fields, S
Publicado: (2001)

The mark of T reg cells
por: Van Epps, Heather L.
Publicado: (2005)

New target for T regs
por: Van Epps, Heather L.
Publicado: (2005)

IPR{reg} : identificación del paciente en riesgo /
Publicado: (2013)

UV-induced T(reg) cells
por: Van Epps, Heather L.
Publicado: (2005)

Tailoring T regs for self preservation
por: Leslie, Mitch
Publicado: (2008)

Half-cocked T reg cells
por: Van Epps, Heather L.
Publicado: (2006)

T reg cells get specific
por: Van Epps, Heather L.
Publicado: (2006)

El Reg's LHC visit
Publicado: (2009)

The expanding impact of T-regs in the skin
por: Hajam, Edries Yousaf, et al.
Publicado: (2022)

Targeting tachykinin receptors in neuroblastoma
por: Henssen, Anton G., et al.
Publicado: (2016)

Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_q6arhej43bj9g566v8r4c2fdvf